<DOC>
	<DOC>NCT00488813</DOC>
	<brief_summary>A single-center, prospective, comparative, antibiotic intervention study for patients admitted to MICU1 and MICU2</brief_summary>
	<brief_title>Study of Antibiotic Utilization Measures and Control of ESBLs in China</brief_title>
	<detailed_description>1. To determine the value of using Î²-lactamases inhibitors in reducing the cases of ESBL producing E. coli or K. pneumoniae colonization and infection after 12 months. 2. To compare the acquisition rates of ESBL producing E. coli or K. pneumoniae at MICU1 and MICU2 after 12 months</detailed_description>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>All patients admitted or transferred to the ICU/burn units. Patients of either sex, 18 years of age or older. Patient with hypersensitivity to penicillins, cephalosporins, and betalactamase inhibitors.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Tzh-Chi ESBL study</keyword>
</DOC>